Understanding the US FDA Drug Review and Approval Process

  • Speaker:Dr. David Lim
  • Duration:75Min
  • Product Code:GRC-90199

$279

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

We offer face to face in person seminar for companies/ corporate. Contact our support to set up a date and price. 
Why should you attend:

The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs.

To introduce a new drug product into the U.S. market, some firms submit a new drug application (NDA) to the US FDA/CDER.

The firms are responsible for testing a drug and for submitting evidence that the drug is safe and effective.

In 2014 and 2015, the FDA/CDER has approved 41 and 45 novel drugs, respectively.

This webinar is intended to help you better understand FDA’s drug review and approval process. The FDA’s recent approvals of novel drugs will also be discussed.

The speaker will walk you through the regulatory requirements for FDA’s drug review and approvals.

Areas Covered in the Session:
  • Laws.
  • Regulations.
  • FDA Guidances.
  • Definitions.
  • Regulatory Requirements for New Drug Application (NDA) and Biologics License Application (BLA).
  • Drug Development.
  • FDA Drug Review and Approval.
  • Common Mistakes.
  • Critical Considerations.
  • Enforcement Actions.
  • Recent FDA Approvals.
  • PASS-IT Recommendations.
Who will benefit :
  • CEOs.
  • VPs.
  • Compliance Officers.
  • Attorneys.
  • Regulatory Affairs.
  • Clinical Affairs.
  • Quality Assurance.
  • R&D.
  • Consultants.
  • Contractors/Subcontractors.
  • Anyone Interested in the FDA Drug Review and Approval Processes.
Instructor Profile:

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. As a leading industry speaker, Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.

Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim currently serves as a member of the Advisory Board for Inspection Insider published by FDA News.

Available Options

Recording: Access the training Recording for 6 months from any location

$279

CD: Shipped within 2 working days

$369

5 Member Group: 5 can Attend Live Meeting Online from any location globally

$2,249

10 Member group: 10 can Attend Live Meeting Online from any location globally

$3,629

Related Products

510(K) Submission - A Comprehensive and an Updated Overview

510(K) Submission - A Comprehensive and an Updated Overview

If you are unable to attend the Live meeting then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Why should you attend:The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical ..

$289

Implementing a (UDI) Unique Device Identification System

Implementing a (UDI) Unique Device Identification System

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Description: This webinar will discuss the regulatory and compliance requirements to implement a system for Unique Device Identification (UDI) including final rules, compliance dates and requirements. The speaker will walk you through the requirements including, but not limited to, what to con..

$279

FDA Regulation of OTC Drugs in the U.S

FDA Regulation of OTC Drugs in the U.S

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. Description: This webinar will cover laws and regulations for successful marketing and compliance of OTC Drugs in the USA. The presentation will provide an overview of FDA OTC Drug regulations with a focus on OTC Drug Labeling requirements. It will help the attendee understand basic regul..

$279

What Pharmaceutical Industry Should do to Adequately Implement a Quality Risk Management System

What Pharmaceutical Industry Should do to Adequately Implement a Quality Risk Management System

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. This presentation is intended to help you get familiar with best practices for quality risk management (QRM) applicable for pharmaceutical industry (drugs, biosimilars, and biologics).This seminar is further intended to discuss how quality risk management can be effectively integrated into ..

$279